Virginia drugmaker hiked the price of an opioid antidote 600% to ‘capitalize’ on epidemic, report claims

By Becker's Hospital Review in Becker's Hospital Review, Channels, Featured
November 19, 2018

Read the full post on Becker's Hospital Review

Becker's Hospital Review